PulpDigital.ai has entered into a licensing agreement with Mayo Clinic to advance artificial intelligence solutions for chronic obstructive pulmonary disease (COPD) healthcare management. The initiative plans to leverage CairIQ, PulpDigital.ai’s flagship AI-driven platform, to address challenges in COPD management, including preventable hospital readmissions, medication adherence, care plan execution, patient engagement, and reducing provider burnout by minimizing low-value administrative tasks. COPD continues to be a leading cause of hospitalizations and readmissions, creating a significant burden on patients and healthcare systems. Through this collaboration, PulpDigital.ai aims to develop and validate innovative, AI-powered approaches to deliver more proactive, personalized,
and continuous care.
Many care models today assume sustained patient behavior change. To address this, CairIQ incorporates a coordinated, four-agent AI care-orchestration “behavior intelligence layer” designed to convert clinical intent into sustained patient action at scale.
The collaboration is slated to have two phases:
Through this collaboration, PulpDigital.ai seeks to:
“This collaboration with Mayo Clinic represents a major milestone for PulpDigital.ai,” said Pervej Alam, Founder, CEO at PulpDigital.ai. “With their support, our goal is to build a next-generation care model that extends beyond hospital walls to empower patients, support
clinicians, and drive measurable improvements in outcomes.
About PulpDigital.AI
PulpDigital.ai is a healthcare AI company focused on improving patient outcomes through intelligent, personalized engagement. Its flagship platform, CairIQ, leverages advanced small language models (SLMs) to enable real-time care orchestration, patient adherence, and clinical decision support across chronic disease management—while also helping reduce provider burnout by automating routine administrative tasks and enabling clinicians to focus on highervalue care.
Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.
Share the article:
Learn more about